best performing mid cap stocks on march 5, 2026

Tango Therapeutics (TNGX) had the highest return on March 5 by a mid-cap US stock, returning 38%.

ASSETDATE% RETURN
Tango Therapeutics (TNGX)
3/5/2026
37.95%
Unifirst (UNF)
3/5/2026
13.97%
Generate Biomedicines, Inc Common Stock (GENB)
3/5/2026
9.79%
Iovance Biotherapeutics (IOVA)
3/5/2026
8.79%
Navan, Inc Class A Common Stock (NAVN)
3/5/2026
7.91%
John Wiley & Sons B (WLYB)
3/5/2026
7.89%
Liquidia Technologies (LQDA)
3/5/2026
7.88%
MakeMyTrip (MMYT)
3/5/2026
7.69%
Braze (BRZE)
3/5/2026
7.57%
Klaviyo (KVYO)
3/5/2026
7.46%
Lionsgate Studios (LION)
3/5/2026
7.07%
Cellebrite DI (CLBT)
3/5/2026
6.97%
Methanex (MEOH)
3/5/2026
6.56%
Credit Acceptance (CACC)
3/5/2026
5.88%
BBVA Banco Frances SA ADR (BBAR)
3/5/2026
5.7%
Caesars Entertainment (CZR)
3/5/2026
5.52%
DoubleVerify (DV)
3/5/2026
5.51%
DXC Technology (DXC)
3/5/2026
5.44%
Erasca (ERAS)
3/5/2026
5.43%
GeneDx (WGS)
3/5/2026
5.41%
John Wiley & Sons (WLY)
3/5/2026
5.21%
Tenable (TENB)
3/5/2026
5.01%
Acadia Healthcare (ACHC)
3/5/2026
4.58%
Vermilion Energy (VET)
3/5/2026
4.51%
Baytex Energy (BTE)
3/5/2026
4.46%
Mid-cap stocks are treated as having a market cap between $2B and $10B.